share_log

Candel Therapeutics Receives Orphan Drug Designation From European Medicines Agency For CAN-2409 In Glioma

Benzinga Real-time News ·  Sep 15, 2022 08:07
Candel Therapeutics Receives Orphan Drug Designation From European Medicines Agency For CAN-2409 In Glioma
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment